Katherine Tuttle

2024

Accelerated Risk-Based Implementation of Guideline-Directed Medical Therapy for Type 2 Diabetes and Chronic Kidney Disease

Neuen, B. L., Tuttle, K. R. & Vaduganathan, M., Apr 16 2024, In: Circulation. 149, 16, p. 1238-1240 3 p.

Research output: Contribution to journal › Comment/debate

23 Scopus citations

2023

National Trends in Glucagon Prescriptions Among U.S. Adults With Diabetes and End-Stage Kidney Disease Treated by Dialysis: 2013–2017

Galindo, R. J., Inselman, S. A., Umpierrez, G. E., Moazzami, B., Mendoza, J. M., Ali, M. K., Tuttle, K. R. & McCoy, R. G., Jul 2023, In: Diabetes Care. 46, 7, p. e130-e132

Research output: Contribution to journal › Comment/debate

Open Access

3 Scopus citations

People with type 1 diabetes and chronic kidney disease urgently need new therapies: a call for action

Heerspink, H. J., Cherney, D. Z., Groop, P. H., Matthieu, C., Rossing, P., Tuttle, K. R. & McGill, J. B., Aug 2023, In: The Lancet Diabetes and Endocrinology. 11, 8, p. 536-540 5 p.

Research output: Contribution to journal › Comment/debate

Open Access

16 Scopus citations

2022

Changing the Trajectory of Heart Failure and Kidney Disease: A Call for Action

Rangaswami, J., Bhalla, V., Chertow, G. M., Harrington, R. A., Staruschenko, A., Tuttle, K. & Braunwald, E., Mar 2022, In: Clinical Journal of the American Society of Nephrology. 17, 5, p. 742-745 4 p.

Research output: Contribution to journal › Comment/debate

Open Access

1 Scopus citations

SGLT2 inhibitors as the bedrock of therapy for heart failure

Tuttle, K. R. & Rangaswami, J., Sep 3 2022, In: The Lancet. 400, 10354, p. 711-713 3 p.

Research output: Contribution to journal › Comment/debate

3 Scopus citations

2021

Annals on call - SGLT-2 revisited: Diabetes management in chronic kidney disease

Centor, R. M., Tuttle, K. R. & Himmelfarb, J., Jun 1 2021, In: Annals of Internal Medicine. 174, 6

Research output: Contribution to journal › Comment/debate

Forecasting therapeutic responses by albuminuria and eGFR slope during the DAPA-CKD trial

Tuttle, K. R., Nov 2021, In: The Lancet Diabetes and Endocrinology. 9, 11, p. 727-728 2 p.

Research output: Contribution to journal › Comment/debate

1 Scopus citations

GLP-1 receptor agonists in diabetic kidney disease

Michos, E. D. & Tuttle, K. R., Oct 2021, In: Clinical Journal of the American Society of Nephrology. 16, 10, p. 1578-1580 3 p.

Research output: Contribution to journal › Comment/debate

Open Access

15 Scopus citations

Glycemic Variability and KIM-1–Induced Inflammation in the Diabetic Kidney

Tuttle, K. R. & Alicic, R. Z., Aug 2021, In: Diabetes. 70, 8, p. 1617-1619 3 p.

Research output: Contribution to journal › Comment/debate

Open Access

7 Scopus citations

Patient perspectives and involvement in precision medicine research

Kidney Precision Medicine Project, Mar 2021, In: Kidney International. 99, 3, p. 511-514 4 p.

Research output: Contribution to journal › Comment/debate

9 Scopus citations

Rationale and design of the Kidney Precision Medicine Project

de Boer, I. H., Alpers, C. E., Azeloglu, E. U., Balis, U. G. J., Barasch, J. M., Barisoni, L., Blank, K. N., Bomback, A. S., Brown, K., Dagher, P. C., Dighe, A. L., Eadon, M. T., El-Achkar, T. M., Gaut, J. P., Hacohen, N., He, Y., Hodgin, J. B., Jain, S., Kellum, J. A. & Kiryluk, K. & 31 others, Knight, R., Laszik, Z. G., Lienczewski, C., Mariani, L. H., McClelland, R. L., Menez, S., Moledina, D. G., Mooney, S. D., O'Toole, J. F., Palevsky, P. M., Parikh, C. R., Poggio, E. D., Rosas, S. E., Rosengart, M. R., Sarwal, M. M., Schaub, J. A., Sedor, J. R., Sharma, K., Steck, B., Toto, R. D., Troyanskaya, O. G., Tuttle, K., Vazquez, M. A., Waikar, S. S., Williams, K., Wilson, F. P., Zhang, K., Iyengar, R., Kretzler, M., Himmelfarb, J. & Kidney Precision Medicine Project, Mar 2021, In: Kidney International. 99, 3, p. 498-510 13 p.

Research output: Contribution to journal › Comment/debate

114 Scopus citations

SGLT2 inhibition and chronic kidney disease outcomes: in diabetes and beyond

Tuttle, K. R., Jan 2021, In: The Lancet Diabetes and Endocrinology. 9, 1, p. 3-5 3 p.

Research output: Contribution to journal › Comment/debate

2 Scopus citations

Therapeutic transformation for diabetic kidney disease

Tuttle, K. & Cherney, D. Z. I., Feb 2021, In: Kidney International. 99, 2, p. 301-303 3 p.

Research output: Contribution to journal › Comment/debate

Open Access

5 Scopus citations

2020

Impact of the COVID-19 pandemic on clinical research

Tuttle, K. R., Oct 1 2020, In: Nature Reviews Nephrology. 16, 10, p. 562-564 3 p.

Research output: Contribution to journal › Comment/debate

Open Access

99 Scopus citations

Sodium glucose cotransporter 2 inhibition heralds a call-to-action for diabetic kidney disease

Tuttle, K. R., Tuttle, K. R. & Cherney, D. Z., Feb 7 2020, In: Clinical Journal of the American Society of Nephrology. 15, 2, p. 285-288 4 p.

Research output: Contribution to journal › Comment/debate

Open Access

21 Scopus citations

2019

A turning point for chronic kidney disease in diabetes

Tuttle, K. R. & Tuttle, K. R., May 11 2019, In: The Lancet. 393, 10184, p. 1913-1914 2 p.

Research output: Contribution to journal › Comment/debate

4 Scopus citations

Erratum: Sodium-glucose cotransporter 2 inhibition and diabetic kidney disease(Diabetes. (2019) 68:2(248-257) DOI: 10.2337/dbi18-0007)

Alicic, R. Z., Neumiller, J. J., Johnson, E. J., Dieter, B. & Tuttle, K. R., 2019, In: Diabetes. 68, 5, p. 1094 1 p.

Research output: Contribution to journal › Comment/debate

1 Scopus citations

SGLT2 inhibitor and incretin mimetic therapy for type 2 diabetes and chronic kidney disease

Tuttle, K., Jun 2019, In: The Lancet Diabetes and Endocrinology. 7, 6, p. 414-415 2 p.

Research output: Contribution to journal › Comment/debate

1 Scopus citations

2017

Back to the future: Glomerular hyperfiltration and the diabetic kidney

Tuttle, K., Jan 1 2017, In: Diabetes. 66, 1, p. 14-16 3 p.

Research output: Contribution to journal › Comment/debate

Open Access

85 Scopus citations

2015

Erratum: Serum amyloid A and inflammation in diabetic kidney disease and podocytes (Laboratory Investigation (2014) DOI: 10.1038/labinvest.2014.163)

Anderberg, R. J., Meek, R. L., Hudkins, K. L., Cooney, S. K., Alpers, C. E., Leboeuf, R. C. & Tuttle, K. R., Jun 28 2015, In: Laboratory Investigation. 95, 6, p. 697 1 p.

Research output: Contribution to journal › Comment/debate

Open Access

14 Scopus citations

2009